| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +80K | 100% | $2.25 | +$180K |
| Sells | 0 | ||||
| Net | +2 | +80K | 100% | +$180K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Wexford Capital Lp | 10%+ Owner | $8.81M | Mar 13, 2024 | ||
| Daron Evans | CEO Specialty Renal Products | $352K | May 24, 2021 | ||
| Arthur Amron | Director | $232K | +$28.3K | +13.9% | May 28, 2024 |
| Andrew Astor | President, CEO & CFO, Director | $204K | Mar 5, 2022 | ||
| Oliver Spandow | Director | $200K | May 14, 2024 | ||
| Robert R. Banks Jr. | President and CEO, Director | $157K | +$152K | +2932% | May 14, 2024 |
| Alisa Lask | Director | $119K | May 14, 2024 | ||
| Tom Gwydir | Director | $95.2K | Jan 5, 2023 | ||
| Wesley S. Lobo | Chief Marketing Officer | $77.5K | Feb 16, 2022 | ||
| Joseph M. Harris | Director | $43.3K | May 14, 2024 | ||
| Judy Krandel | Chief Financial Officer | Nov 1, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|